+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neuropathologic effects of phenylmethylsulfonyl fluoride -induced promotion and protection in organophosphorus ester-induced delayed neuropathy in hens

Neuropathologic effects of phenylmethylsulfonyl fluoride -induced promotion and protection in organophosphorus ester-induced delayed neuropathy in hens

Neurotoxicology (Little Rock) 20(5): 749-760

The serine/cysteine protease inhibitor phenylmethylsulfonyl fluoride (PMSF) has been used both to promote and to protect against neuropathic events of organophosphorus-induced delayed neuropathy (OPIDN) in hens (Veronesi and Padilla, 1985; Pope and Padilla, 1990; Lotti et al., 1991; Pope et al., 1993; Randall et al., 1997). This study is the first to expand upon this work by using high resolution microscopy provided by epoxy resin embedding and thin sectioning to evaluate neuropathological manifestations of promotion and protection, and to correlate them with associated clinical modifications. To evaluate dose-related effects of OPIDN, single phenyl saligenin phosphate (PSP) dosages of 0.5, 1.0, or 2.5 mg/kg were administered to adult hens. PMSF (90 mg/kg) was given either 4 hours after (for promotion) or 12 hours prior to (for protection) PSP administration. Clinical signs and pathologic changes in the biventer cervicis nerve, which is uniquely sensitive to OPIDN (El-Fawal et al., 1988), were monitored. PSP alone, 2.5 mg/kg, caused severe OPIDN (terminal clinical score 7.5 +- 1.0 (0-8 scale); neuropathology score 2.7 +- 0.3 (0-4 scale, based on myelinated fiber degeneration)). PMSF given 12 hours prior to PSP gave complete protection (clinical and neuropathology scores of 0; p<0.0001 compared to PSP alone). Signs and lesions of OPIDN were absent following 0.5 mg/kg PSP alone, but PMSF given 4 hours after PSP potentiated its neurotoxic effects (all hens had clinical scores of 4.0 and the average neuropathology score was 3.5 +- 0.3; p<0.0001 compared to PSP alone). Although quantitative differences were noted, qualitative differences among nerves from hens with OPIDN were not evident, either with light or electron microscopy. At the time of sacrifice, there was a statistically linear relationship (r2 = 0.76) between the clinical scores on the last day of observation and the neuropathology scores (p<0.0001). This study demonstrates that the degree of peripheral nerve myelinated fiber degeneration correlates with clinical deficits in PMSF-induced potentiation of and protection against OPIDN.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 035381430

Download citation: RISBibTeXText

Related references

Neuropathologic effects of phenylmethylsulfonyl fluoride (PMSF)-induced promotion and protection in organophosphorus ester-induced delayed neuropathy (OPIDN) in hens. Neurotoxicology 20(5): 749-759, 1999

Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. Journal of Toxicology and Environmental Health 31(4): 261-273, 1990

Semi-quantitative morphologic techniques for evaluation of organophosphorus ester-induced delayed neuropathy in hens. Society for Neuroscience Abstracts 25(1-2): 569, 1999

Comparative dose-response studies of organophosphorus ester-induced delayed neuropathy in rats and hens administered mipafox. Neurotoxicology 13(4): 745-755, 1992

Phenylmethylsulfonyl fluoride alters sensitivity to organophosphorus-induced delayed neurotoxicity in developing animals. Neurotoxicology 13(2): 355-364, 1992

Phenylmethylsulfonyl fluoride protects rats from Mipafox-induced delayed neuropathy. Toxicology and Applied Pharmacology 81(2): 258-264, 1985

Phenylmethylsulfonyl fluoride protects against the degradation of neurofilaments in tri-ortho-cresyl phosphate (TOCP) induced delayed neuropathy. Toxicology 262(3): 258-264, 2009

The time course of protection from delayed neuro toxicity induced by tri o cresyl phosphate and dfp by phenylmethylsulfonyl fluoride in chickens. Toxicology Letters 18(3): 251-256, 1983

Lack of correlation of organophosphorus-induced delayed neuropathy with neuropathy target esterase in hens and Japanese quails. Journal of Health Science 45(4): 209-216, 1999

Effect of verapamil on organophosphorus-induced delayed neuropathy in hens. Toxicology and Applied Pharmacology 97(3): 500-511, 1989

Effects of various post-treatment by phenylmethylsulfonyl fluoride on delayed neurotoxicity induced by leptophos. Journal of Toxicological Sciences 20(5): 609-617, 1995

Optimal conduct of the neuropathology evaluation of organophosphorus induced delayed neuropathy in hens. Experimental and Toxicologic Pathology 49(6): 451-458, 1997

Glucose metabolism in hens after the intravenous administration of organophosphorus pesticides induced delayed neuropathy. Sumino, K (Ed ) Environmental And Occupational Chemical Hazards, No 8; Asia-Pacific Symposium on Environmental And Occupational Toxicology, Singapore, October 4-7, 1987 Xii+582p Kobe University School Of Medicine: Kobe, Japan Illus Maps : 547-552, 1988

Myelinated nerve fiber regeneration following organophosphorus ester-induced delayed neuropathy. Neurotoxicology 10(4): 717-726, 1989

Identification of differentially expressed proteins related to organophosphorus-induced delayed neuropathy in the brains of hens. Journal of Applied Toxicology 34(12): 1352-1360, 2014